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Abstract Neuroimaging studies have gained increasing
importance in validating neurobiological network hypoth-
eses for anxiety disorders. Functional imaging procedures
and radioligand binding studies in healthy subjects and in
patients with anxiety disorders provide growing evidence
of the existence of a complex anxiety network, including
limbic, brainstem, temporal, and prefrontal cortical
regions. Obviously, ‘‘normal anxiety’’ does not equal
‘‘pathological anxiety’’ although many phenomena are
evident in healthy subjects, however to a lower extent.
Differential effects of distinct brain regions and laterali-
zation phenomena in different anxiety disorders are
mentioned. An overview of neuroimaging investigations in
anxiety disorders is given after a brief summary of results
from healthy volunteers. Concluding implications for
future research are made by the authors.
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Introduction
There has been an enormous increase in studies on anxiety
disorders implying neuroimaging procedures. Improved
techniques for structural imaging such as computed
tomography studies and structural MRI have brought
diverse results and hypotheses on the neuroanatomy of
anxiety up from the 1980s. However, the ﬁndings of these
studies hardly correspond.
In 1980, research and classiﬁcatory criteria for anxiety
disorders have emerged in DSM-III. These made stan-
dardized investigations methodologically possible and with
the improvement of a neurophysiological and neurobio-
logical understanding of anxiety disorders the idea of a
neural anxiety network consolidated. With distinct neo-
cortical, limbic, and brainstem structures involved in the
generation and processing of anxiety symptoms and dis-
orders, the need for conﬁrmation has become the incentive
of neuroimaging studies. Considering the enormous meth-
odological progress, imaging procedures gain an increasing
importance in research on the pathogenesis of anxiety
disorders. There is growing evidence that brain areas
involved in the stress response, including the prefrontal
cortex, hippocampus and amygdala, play a role in the
symptoms of anxiety. In the past few years, brain imaging
studies have been dedicated to the progress of under-
standing of the neural circuitry of anxiety disorders
(Bremner 2004).
However, it has became obvious that some areas
involved in anxiety processing like the amygdalae, distinct
brainstem nuclei or the periaquaductal gray (PAG) are hard
to detect with sufﬁcient resolution because of their sizes
and anatomical locations (closeness to structures of dif-
ferent density like bone or body liquids). Nevertheless,
with increasing quality of methods, results become more
and more precise and now allow for a consolidation of
neuronal network hypotheses in anxiety disorders. Radio-
ligand studies and investigations on regional cerebral blood
ﬂow [using e.g. positron emission tomography (PET) and
single photon emission computed tomography (SPECT)]
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binding of ligands in distinct regions compared to control
conditions such as healthy subjects or pre/post treatment
differences. The past years have brought about a number of
studies using high resolution functional magnetic reso-
nance imaging, which provide valid statements for
different stimulation paradigms in patients with anxiety
disorders and in stimulated healthy subjects. Such stimu-
latory conditions can be either psychological or
pharmacological and correlate with regional changes of
activity.
Investigations incorporated into this review have been
chosen on the base of a med-line research with the
keywords neuroimaging and either panic disorder, agora-
phobia, social anxiety disorder or generalized anxiety
disorder. Due to their large amount, research articles on
speciﬁc phobia have been selected on the base of their
impact on disorder speciﬁc neuroanatomical models, as
judged by the authors. Out of the plenty of animal imaging
data and ﬁndings in healthy human subjects only few
exemplary articles have been chosen to facilitate the
introduction to anxiety disorder speciﬁc models.
In line with both classiﬁcatory systems DSM-IV
(American Psychiatric Association 1998) and ICD-10
(World Health Organisation 1993) and in order to make
this article as concise as possible, no research articles
on post-traumatic stress disorder (PTSD) and obsessive–
convulsive disorder (OCD) have been implemented.
Due to the relative unspeciﬁcity and the limitations of
structural imaging data, their presentation is kept short in
this article.
Following a brief introduction about selected ﬁndings
from animal studies and healthy probands, an overview on
neuroimaging research work is given and implications for
future perspectives are made. Brief introduction to the
clinical syndrome of the respective disorders are given in
the beginning of each chapter and preliminary conclusions
from the research data are tried to be made.
Implications from animal research
In anxiety paradigms, it has become evident that the medial
prefrontal cortex plays an essential role in the inhibition of
conditioned fear following extinction. These neuronal
pathways inhibit central amygdala nucleus output and
inputs from the insula and basolateral amygdala (Quirk
et al. 2003). Amat et al. (2005) showed that the ventral
medial prefrontal cortex in rats detects whether a stressor is
under control of the organism. If this is the case, dorsal
raphe activity is blocked.
Milad and Quirk (2002) showed that destruction of the
ventral medial prefrontal cortex in animals impairs recall of
extinction. This structure might store long-term extinction
memory and inhibits fear in subsequent encounters with
fear stimuli. Thus, previously learned coping strategies
with external and internal stressors would be processed
from this region.
Healthy subjects
Functional magnetic resonance imaging (fMRI)
Using fMRI during a fear conditioning paradigm in healthy
subjects, amygdalae activation was increased (LaBar et al.
1998). Another investigation showed amygdalae activation
on presentation of non-conditioned, fear-related or nega-
tively affect-loaded stimuli, too (Grodd et al. 1995).
Gottfried and Dolan (2004) could demonstrate that in
humans that orbitofrontal cortex and amygdalae activity
were preferably enhanced during extinction learning of
previously conditioned aversive stimuli. Etkin et al. (2006)
found that activity in the amygdala and dorsomedial and
dorsolateral prefrontal cortices reﬂects the amount of
emotional conﬂict, when a coping-strategy seems not to be
directly available. The amygdala activation appears to be
personality dependent and correlates with neuroticism
(Haas et al. 2007). Final resolution of the emotional con-
ﬂict goes in line with anterior cingulate cortex (ACC)
activity and correlates with reduction of amygdalae activity
(top-down inhibition). Herry et al. (2007) suggested that
amygdala function increases with the unpredictability of
a stimulus or situation. Paulus et al. (2004), however,
implied that activation of the ACC and medial prefrontal
cortex was signiﬁcantly higher in high trait-anxiety sub-
jects and was correlated with trait but not state anxiety.
Possibly, this feature characterizes subjects who scan their
environment more thoroughly for anxiety inducing stimuli
but also for coping factors. According to (Phelps et al.
2004), ventromedial prefrontal cortex activation (anterior
cingulate) seems to be primarily linked to expression of
fear learning during delayed tests of extinction.
Jensen et al. (2003) proposed that the ventral striatum,
which is associated with the reward system, is activated in
anticipation of adverse stimuli. Yet, Yaguez et al. (2005)
showed that actual and anticipated aversive stimuli (pain)
elicited similar cortical responses, including activation
of ACC, insula, primary and secondary somatosensory
cortices. This is in line with Simmons et al. (2004),
who observed insula, dorsolateral prefrontal cortex, and
parahippocampal gyrus activation during anticipation of
aversive affective images. Interestingly, Critchley et al.
(2002) demonstrated that conditioning-related neural
activity is modulated by both awareness and representa-
tions of bodily states and autonomic arousal. Absent
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123peripheral autonomic arousal, in patients with autonomic
denervation was associated with decreased conditioning
related activity in insula and amygdala.
In a meta-analysis of PET and fMRI studies on emotion
in healthy volunteers, (Phan et al. 2002) proclaimed certain
brain regions to be associated to distinct emotions and
executive functions, e.g. the amygdalae for fear and the
medial prefrontal cortex for emotional processing. In a
recent fMRI study by Dannlowski et al. (2007), however, it
could be demonstrated that amygdala hyperreactivity cor-
related with negative automatic emotion processing (in
depressive patients). Activity in the basolateral amygdala
elicited by unconscious emotional processing was pre-
dicted by individual differences in trait anxiety in healthy
subjects using fMRI. This phenomenon was not detected in
the dorsal amygdala that is modulated by conscious emo-
tional processing (Etkin et al. 2004). High trait anxiety
healthy subjects display higher amygdala and insula acti-
vation during processing of emotional stimuli compared to
a normative group (Stein et al. 2007). State anxiety, how-
ever, is associated with higher ventral amygdala responses
in healthy subjects (Somerville et al. 2004). Application of
the selective serotonin re-uptake inhibitor escitalopram
over 21 days could signiﬁcantly reduce amygdala activa-
tion during an emotional task compared to placebo in
healthy probands (Arce et al. 2008). This may well ﬁt into a
theoretical framework of negative emotional processing as
suggested by LeDoux (1996) stressing an unconscious,
‘‘fast’’ way of automatic amygdala mediated responses to
potentially threatening stimuli.
Nevertheless, in a classical conditioning paradigm using
PET, healthy subjects reacted to stimulation with an
increase of cerebral blood ﬂow (CBF) in the thalamus,
hypothalamus, periaqueductal grey (PAG) and cingulate
but not in the amygdalae (Fredrikson et al. 1995; Furmark
et al. 1997; Morris et al. 1996).
Chemically induced anxiety
The panicogen cholecystokinine-tetrapeptide (CCK-4) is a
neurokinine binding to central nervous and peripheral sites.
Intravenous application causes a dose-dependent brief and
impetuous anxiety state with psychic and somatic anxiety
symptoms. Infusion of CCK-4 in healthy subjects increased
activity in the cerebellar vermis, both temporal lobes and
amygdalae, thalamus and anterior cingulate as measured
with fMRI. Anticipatory anxiety activated temporal lobes
and insulae, right prefrontal cortex, thalamus, cingulate and
the temporo-parieto-occipital gyrus (Schunck et al. 2006).
Eser et al. (2007) reported an intense ACC, medial frontal
cortex, and temporal lobe activation in healthy subjects by
CCK-4 compared to placebo in healthy subjects. Anti-
cipatory anxiety phenomena were less pronounced and
related to the dorsal ACC. Effects were independent of the
occurrence of a panic attack, subjective levels of anxiety
correlated with amygdala activation.
Panic disorder
Panic disorder is a condition characterized by repeated
limited episodes of intense somatic and psychic anxiety
symptoms. Symptoms such as dyspnea, palpitations,
tachycardia, sweating, tremor, nausea and depersonaliza-
tion, fear of losing control or dying emerge in speciﬁc
situations or ‘‘out of the blue’’ and increase within a few
minutes. Such panic attacks usually result in an intense and
ongoing fear of the next expected attack (phobophobia).
This may lead to avoidance behaviour with patients
refraining situations in which they may become helplessly
panicky. Panic disorder very often is associated with ago-
raphobia, a fear of certain situations (such as elevators,
wide places, crows of people, theatres) from which ﬂeeing
is expected to be difﬁcult.
Structural imaging
Computed tomography (CT)
In a number of CT studies, some distinct structural alter-
ations in panic disorder patients were detected in low to
medium sample sizes. Most results were rather unspeciﬁc
[demonstrating enlarged ventricles in the prefrontal cortex
(Wurthmann et al. 1997)], slight atrophy, diminished brain/
ventricles ratio or lacunary infarctions, and could not be
replicated [e.g. normal brain/ventricles ratio (Uhde et al.
1987)]. Lepola et al. (1990) found structural abnormalities
in 6 of 30 panic patients. In conclusion, CT cannot be
regarded as an appropriate tool for investigating the
neuroanatomy of panic anxiety due to its low resolution.
Magnetic resonance imaging (MRI)
Structural MRI-studies revealed hardly more speciﬁc and
conclusive results compared to CT investigations. In panic
patients structural alterations were found in the temporal
lobes, predominantly on the right side (Fontaine et al.
1990; Ontiveros et al. 1989). One investigation reported
diminished volumina of both temporal lobes, despite
unaltered hippocampi (Vythilingam et al. 2000).
Uchida et al. (2003) found a reduced left temporal lobe
volume and a trend to reduced right temporal lobe, left and
right amygdala and the left hippocampal area volume.
One study indicates reduced grey matter density in the
left hippocampus of panic patients (Massana et al. 2003a).
Another morphometric investigation on panic disorder
patients revealed higher grey matter volume in the
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extent in the ventral hippocampus combined with less
prefrontal cortex volume (Protopopescu et al. 2006). A
voxel-based morphometric study found bilaterally dimin-
ished putamen volumina (Yoo et al. 2005). Volumetric
magnetic resonance imaging (MRI) studies performed by
Massana et al. (2003b) found patients to have smaller left-
sided and right-sided amygdala volumes than controls. No
differences were detected in either hippocampi or temporal
lobes.
Functional imaging
Regional cerebral blood ﬂow (CBF) under basal conditions
Three studies investigated basal CBF in patients suffering
from panic disorder. In one [
18FDG]-PET investigation, a
lowered metabolic rate in the left inferior parietal lobe was
found compared to controls (Nordahl et al. 1990). Posterior
temporal lobe, inferior parietal lobe and cerebellar cortex
CBF was decreased bilaterally (Malizia et al. 1998),
whereas on study showed increased CBF in the left hip-
pocampus (Bisaga et al. 1998).
Sakai et al. (2005) accessed cerebral glucose metabolism
in patients with panic disorder using F-ﬂuorodeoxyglucose
positron emission tomography with voxel-based analysis
to compare regional brain glucose utilization and showed
that patients exhibited signiﬁcantly higher levels of glucose
uptake in the bilateral amygdala, hippocampus, and thala-
mus, and in the midbrain, caudal pons, medulla, and
cerebellum than controls. After successful treatment both
cognitive behavioural treatment and antidepressant treat-
ment resulted in comparable decreases of previous
activations (Prasko et al. 2004).
On trial implying Tc99m-HM-PAO-SPECT in panic
patients detected a bilateral frontal decrease and a right
pronounced medial and superior frontal increase of regio-
nal blood-ﬂow. CBF asymmetry with a shift to the right
side correlated with disorder severity as measured with the
Bandelow Panic and Agoraphobia Scale (P&A) (Eren et al.
2003). Comparable results were found by Lee et al. (2006)
with patients showing decreased CBF in the right upper
temporal lobe. CBF in this region was negatively correlated
with panic disorder severity.
GABA-/benzodiazepine receptors
[
11C]Flumazenil binding to benzodiazepine receptors was
generally diminished in patients compared to controls,
especially in the right insular region and in the right
orbitofrontal cortex (Malizia et al. 1998). These results
could be replicated lately by Cameron et al. (2007)
who showed diminished binding in the insular cortices
bilaterally correlating with disorder severity and comorbid
depression.
Several studies used [
123I]Iomazenil-SPECT to investi-
gate benzodiazepine receptor binding.
Kuikka et al. (1995) found increased iomazenil signal-
ling in the temporal cortex and in the right laterofrontal
gyrus in drug-free panic disorder patients compared to
healthy controls. Brandt et al. (1998) compared drug-free
patients and controls as well and found increased iomazenil
binding in the right orbitofrontal cortex. The left hippo-
campal area revealed less benzodiazepine-receptor binding
(Bremner et al. 2000).
One investigation compared panic disorder patients with
patients suffering from epilepsy showing lower iomazenil-
uptake in the frontal, occipital and temporal cortex
(Schlegel et al. 1994).
Comparing panic patients with comorbid major
depression to patients suffering from dysthymia, who were
all on antidepressant medication, a lower iomazenil bind-
ing in both lower lateral temporal lobes, in the left medial
inferior temporal lobe and in both orbitofrontal lobes could
be demonstrated for panic disorder (Kaschka et al. 1995).
Using
1H-magnetic resonance spectroscopy, a reduced
GABA concentration in the occipital cortex could be
measured (Goddard et al. 2001).
In a consequent trial, the authors could ﬁnd a lowering
of occipital GABA reduction after benzodiazepine admin-
istration (Goddard et al. 2004).
Another study revealed signiﬁcantly decreased GABA
concentration in the anterior cingulate (ACC) and in the
basal ganglia in panic patients compared to controls (Ham
et al. 2007). Lactate and choline concentrations in the ACC
in patients were higher.
Serotonin binding studies
In one PET study, a reduced serotonin-5-HT1A-receptor
binding in the cingulate and raphe nuclei could be found
(Neumeister et al. 2004).
Maron et al. (2004) found that patients with current PD
showed a signiﬁcant decrease in 5-HT transporter binding
in the midbrain, temporal lobes and thalamus compared to
controls by SPECT. Regional binding signiﬁcantly and
negatively correlated with the severity of panic symptoms.
The binding in patients in remission, however, was com-
parable to ﬁndings in the control group.
Creatine and phosphocreatine are metabolites involved
in energy dependent brain systems. In the frontal lobes of
panic patients a higher phosphocreatine concentration was
found on the left side (Shioiri et al. 1996).
1H-magnetic resonance spectroscopy revealed a reduced
creatine/phosphocreatine concentration in the medial pre-
frontal cortex in one study (Massana et al. 2002).
706 K. Engel et al.
123Anxiety provocation and challenge tests
Provocation of presentation of visual anxiety-related
stimuli
After presentation of potentially threatening words, panic
patients displayed activation in the left posterior cingulum
and the left medial frontal cortex (Maddock et al. 2003)i n
the f-MRI.
On presentation of words with negative emotional
valence patients reacted with an activation of the right
amygdala and right hippocampus (van den Heuvel et al.
2005).
Stimulation with anxiety related pictures went in line
with increased activity in the inferior frontal cortex, the
hippocampus, the anterior and posterior cingulate and the
orbitofrontal cortex (Bystritsky et al. 2001).
On presentation of anxious faces panic patients dis-
played, compared to controls, a lower activation of the
anterior cingulate cortex and the amygdalae (Pillay et al.
2006). This was discussed in a way that patients had
a reduced reaction to acute emotional cues because of a
chronic hyperarousal. Happy faces went in line with a
bilateral activation of the anterior cingulate cortices but not
with amygdala alterations (Pillay et al. 2007).
Domschke et al. (2006) reported correlations between
distinct genetic polymorphisms of the serotonergic system
and a lower activation of the right prefrontal cortex and
increased activity of both amygdalae after presentation of
faces with emotional expressions.
Panic provocation by sodium lactate infusions
Panic provocation with sodium lactate or other panicogens
can be associated with artefacts by induced vasoconstric-
tion (Ball and Shekhar 1997). Also, respiratory changes
caused by acute (state anxiety) or continuous (trait anxiety)
fear and anxiety may inﬂuence results of functional MR
imaging (Giardino et al. 2007).
In one PET study by (Reiman et al. 1989) a decreased
left to right ratio of parahippocampal CBF was seen in
panic disorder patients. However, these results could not be
replicated by (Drevets et al. 1992) and turned out to be
artefacts by extracerebral signals, namely patients’ gritting
of teeth.
In a trial using 99mTc-HM-PAO-SPECT seven sodium-
lactate sensitive panic disorder patients were compared to
ﬁve healthy controls (De Cristofaro et al. 1993). In the
patient group, increased CBF in the right orbitofrontal
cortex was detected. Additionally, CBF was higher in the
left occipital cortex and lower bilaterally in the hippo-
campus and the amygdalae. Using [
133Xe]-SPECT, patients
who did not panic after sodium lactate as well as in
controls, hemispheric CBF after the infusion was increased
(Stewart et al. 1988). This was not the case in patients who
had panicked, but maybe because of induced hyperventi-
lation decreasing CBF. Yet, patients who experienced a
panic attack had an increase of CBF in the occipital lobe.
Sodium-lactate infusion causes an increased lactate
concentration in the brain. The increase is more pro-
nounced in panic disorder patients than in controls. This
was demonstrated using proton echo planar spectroscopic
imaging (PEPSI). Particular regions not displaying such an
increase could not be identiﬁed (Dager et al. 1999).
Panic patients had a larger and prolonged sodium lactate
increase in the insular cortices (Dager et al. 1994, 1997)a s
detected by magnetic resonance spectroscopy (MRS).
Panic provokation by yohimbine
During yohimbine-induced anxiety, cerebral vasocons-
triction was observed. Patients showed an attenuated
activation of the frontal cortex compared to controls using
HM-PAO-SPECT (Woods et al. 1988).
Panic provocation by cholecystokinine (CCK)
After CCK induced anxiety healthy volunteers displayed
an increase of extracerebral blood ﬂow in the region of the
superﬁcial temporal artery (Benkelfat et al. 1995)a s
measured by PET. The authors hypothesized that regional
blood ﬂow changes that were measured in previous study
might be caused by muscular activity.
There is one study which investigated anticipatory
anxiety before infusion of the CCK-B agonist pentagastrin.
After the challenger there was no more hypothalamic CBF
increase but a larger activity of the right amygdala
(Boshuisen et al. 2002).
Panic provocation by doxapram
In response to the respiratory stimulant doxapram, which
can induce panic attacks, panic disorder patients tended
to decrease prefrontal activity more than controls, and
increased cingulate gyrus and amygdala activity more than
controls (Garakani et al. 2007).
Spontaneous panic attacks
Pﬂeiderer et al. (2007) recently reported on a female
patient with panic disorder experiencing an (accidental)
spontaneous panic attack under an auditory habituation
paradigm in fMRI at 3 T. This is the ﬁrst report on spon-
taneous panic under such conditions. The panic attack was
associated with a signiﬁcantly increased activity in the
right amygdala.
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Neurocircuitry models of panic disorder have hypothesized
that the panic attack itself stems from loci in the brainstem
including the ascending reticular system and respiratory
and cardiovascular control centres. Panic might be con-
trolled as well as to originate from a dysfunction of frontal
and temporal limbic circuitries. According to Gorman et al.
(2000) a neuronal ‘‘fear network’’ centered in the amygdala
is controlled by medial prefrontal areas via the hippo-
campus. Amygdala projections to brainstem nuclei might
account for many of the somatic anxiety symptoms during
a panic attack. Entero- and exteroceptive awareness might
be increased by a greater reagibility of the insular cortex. In
subsequent phenomena such as expectancies (‘‘fear of
fear’’) and avoidance prefrontal cortical areas obviously
appear to be predominantly involved. Side asymmetries
with decreased activity of inhibitory, prefrontal structures
and increased activity in limbic areas on the dominant
hemisphere are evident. However, many studies cannot be
considered conclusive because of several methodological
limitations, and challenge paradigms are not easy to per-
form in this patient group in the scanner. Despite of this,
the amount of investigations in panic disorder exceeds
the number of those in the other anxiety disorders by far.
Volpe et al. (2004) suggested longitudinal and multi-modal
studies involving larger patient samples, possibly inte-
grated with population-based and genetic studies, would
provide more insight into pathophysiological mechanisms
of panic disorder. Nevertheless, a dysfunctional seroto-
nergic system might be of importance since several
parameters associated with serotonergic function are
altered in panic disorder and treatment with serotonergic
drugs can reduce activity of distinct regions of the ‘‘fear
network’’ in the direction of controls.
Generalized anxiety disorder (GAD)
Generalized anxiety disorder is a disorder characterized by
continuous symptom of anxiety and vegetative hyper-
arousal associated with extreme and exaggerated sorrows.
Sorrows might deal with thoughts that relatives or family
members could be harmed or have an accident when they
are out of the patient’s control. Sorrows may also be about
ﬁnancial or occupational issues. Patients are aware that
their fear of anything adverse happening is not realistic and
that their sorrows are exaggerated (meta-sorrows).
Structural imaging
In comparatively small samples of GAD and panic disorder
patients some subjects revealed unspeciﬁc CCT alterations
such as enlarger ventricles (Lauer and Krieg 1992). Com-
pared to children with panic attacks, children with GAD
had a higher grey to white matter ratio in the upper tem-
poral lobe. This was more pronounced on the right side,
whereas there were no differences in the thalamus and the
frontal cortex (De Bellis et al. 2002).
Functional imaging
Only over the recent years, results from imaging studies
allow for differentiated statements about regional CBF
alterations (Nutt 2001). Under basal conditions no consis-
tent changes were observed. Under psychological stress,
however, a reduction of CBF was found (Nutt 2001). Using
xenon-inhalation-technique a negative correlation between
CBF and anxiety could be shown. Nevertheless, under
resting conditions no differences to controls emerged
(Mathews and Wilson 1987).
Positron emission tomography investigations revealed
increased metabolism in the occipital, temporal, frontal,
and cerebellar region and a lower CBF in the basal ganglia
of patients with GAD after presentation of an anxiety-
inducing task (Wu et al. 1991). Under comparable condi-
tions an ampliﬁcation of activity emerged in the basal
ganglia (Buchsbaum et al. 1987). Mathew et al. (2004)
recently described that GAD patients had a 16.5% higher
N-acetylaspartate/creatine ratio, a suggested marker of
neuronal viability, in the right dorsolateral prefrontal cor-
tex compared with healthy controls. A total of 13 of 15
matched patient-comparison subject pairs displayed such a
difference. In a recent meta-analysis (Etkin and Wager
2007) greater amygdala and also insula activity was
reported for GAD in negative emotional processing com-
pared to healthy controls. Patients with GAD had a better
treatment response to ﬂuoxetine or cognitive behavioural
therapy when pre-treatment amygdala activity was strong
(McClure et al. 2007). Treatment response to venlafaxine,
however, was predicted by lower amygdala and higher
ACC reactivity to fearful faces in the fMRI (Whalen et al.
2008). With regard to prefrontal activity Monk et al.
(2006) found greater fMRI BOLD responses in the right
ventrolateral prefrontal cortex to emotionally adverse
stimuli compared to healthy controls. In adolescents with
GAD disorder severity correlated positively with right
amygdala activation on presentation of angry faces. This
ﬁnding was negatively associated to right ventrolateral
prefrontal cortex activity, a phenomenon that was evident
to an even higher degree in healthy controls (Monk et al.
2008).
There is still a relative paucity of GAD studies.
Amygdala and insula function seem to be of importance in
this disorder and a dysfunction of the ventrolateral pre-
frontal cortex could be of relevance.
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Social anxiety disorder is characterized by extreme and
exagerated fears of being scrutinized by others and to be a
target of criticism leading to awkward situations. Social sit-
uations(e.g.publicspeaking,performances,interactionswith
authority persons or members of the opposite sex) in which
the subjects expects his appearance and behaviour to be
evaluated by others (mostly unfamiliar persons) are avoided
or tolerated with intense anxiety symptoms which are again
expectedtobedetectedbyothers.Panicattacksmayoccurin
thecourseofthisdisorder.Aperformancetype,aninteraction
type, and a generalized type can be distinguished.
Structural imaging
The study by Potts et al. (1996) found an overall volume
reduction of the putamen of patients compared to controls
by MRI.
Functional imaging
Phobic stimulation paradigms
Birbaumer et al. (1998) showed bilateral amygdalae acti-
vation in SAD patients under phobic stimulation using
fMRI. Stein et al. (2002) however, investigated a signal
increase in amygdalae, uncus, and gyrus parahippocamp-
alis in patients in the fMRI on presentation of faces
expressing negative affectivity, exclusively. This could be
conﬁrmed by Evans et al. (2007) and Phan et al. (2006)i n
generalized SAD patients who were shown aversive faces
displaying higher amygdalae activation. The extent of
activation correlated with SAD severity and was reversible
after antidepressant treatment (Norbury et al. 2007).
Lorberbaum et al. (2004) scanned generalized social
phobics anticipating public speaking by fMRI. They
showed greater subcortical, limbic, and lateral paralimbic
activity (pons, striatum, amygdala, uncus, anterior para-
hippocampus, insula, temporal lobe), regions important in
automatic emotional processing. Cortical activity (dorsal
ACC, prefrontal cortex) (important for cognitive process-
ing) was reduced. Interestingly, Campbell et al. (2007)
could demonstrate that amygdala and prefrontal cortex
responses to emotional faces occurred later in generalized
social phobics than in healthy controls.
Kilts et al. (2006) demonstrated in PET scans of SAD
subjects that mental imagery resulted in left postcentral
gyrus, lenticulate right inferior frontal gyri and medial
temporal gyri activity. Mental arithmetic tasks activated
medial and left dorsolateral prefrontal cortex, cerebellum,
thalamus, insula and ventral striatum. Both conditions went
in line with right amygdala and hippocampus activation.
In paired conditioning paradigms—simultaneous pre-
sentation of a conditioned (neutral facial expression) and
an unconditioned stimulus (neutral or aversive odour)—
patients displayed a signiﬁcant increase in amydalae and
hippocampus activity compared to control subjects
(Schneider et al. 1999). fMRI scans by Straube et al. (2005)
demonstrated increased activity in the extra-striate visual
cortex on presentation of faces regardless of expression.
Angry faces, however, elicited greater insula activation.
Amygdala, parahippocampal gyrus and extra-striate visual
cortex were more strongly activated in an implicit subtask
(type of picture, not expression) (Straube et al. 2004b).
Yoon et al. (2007) also reported higher bilateral amygdala
activation in generalized social phobics compared to
healthy controls when faces with high emotional intensity
were presented.
Kagan described a childhood phenomenon ‘‘behavioural
inhibition’’ that is characterized by avoidance of novel
stimuli, objects and situations. Adults who had been
diagnosed as ‘‘inhibited’’ in the second year of life showed
a more pronounced amygdala activation in the fMRI on
presentation of unfamiliar faces (Schwartz et al. 2003).
One SPECT-study found no differences with regard to
CBF between SAD and healthy subjects (Stein and Leslie
1996).
After provocation by phobic stimuli PET showed a
signal increase in the right prefrontal cortex and in the left
parietal cortex. This phenomenon did not show under
phobic anticipation in controls (Malizia et al. 1997).
Another PET study was performed to measure SAD
patient’s CBF in a state of anticipatory anxiety before
public speaking. An increased CBF in the right dorsolateral
prefrontal cortex, the left inferior temporal cortex and the
left hippocampus-amydala complex was detected, addi-
tionally a decrease of CBF in the left temporal pole and
bilaterally in the cerebellum.
During and after stimulation SAD patients showed an
overall increase of subcortical CBF compared to healthy
controls who had an elevation of cortical CBF (Tillfors
et al. 2002). Similar elevations of CBF in generalized SAD
in the thalamus, midbrain, the lateral, prefrontal and medial
cingulum, and the sensomotoric, anterotemporal cortex
were stated by investigations by Reiman (1997). Under
stimulatory conditions a decrease of activity in the visual-
and the mediofrontal cortex could be demonstrated (van
Ameringen et al. 1998).
Metabolic changes, treatment effects, and serotonergic
function
Davidson et al. (1993) and Tupler et al. (1997) could dis-
tinguish different distributions of amino-acids by magnetic
resonance tomography in SAD patients for instance in the
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investigations a lower metabolic rate in the basal ganglia of
patients with SAD was proposed. Magnetic resonance
spectroscopy revealed an increased uptake of ﬂuoxetine in
distinct areas of the brain in SAD patients who had
improved clinically signiﬁcantly under this treatment
before (Miner et al. 1995). Successful pharmacotherapy
reduced activity in the left temporal lobe, left frontal cortex
and left cingulum as accessed by HMPAO-SPECT (van der
Linden et al. 2000). In a PET study after phobic stimula-
tion, SAD patients who had clinically improved under
citalopram treatment had decreased CBF in both amygda-
lae, hippocampus, and in the paraamygdaloid, rhinal, and
parahippocampal cortex compared to measurements before
pharmacological treatment. Changes correlated obviously
with clinical improvement and differed signiﬁcantly to
untreated controls (Furmark et al. 2002). More evidence for
a serotonergic dysfunction was given by Lanzenberger
et al. (2007) who found a signiﬁcantly lower 5-HT1A
receptor binding in several limbic and paralimbic areas of
SAD patients, most signiﬁcantly in the amygdala followed
by the anterior cingulate cortex, insula, and dorsal raphe
nuclei.
Recent theories propose a dysfunction of the dopami-
nergic system in SAD. Using the cocaine analogue [
123I]-
Beta-CIT a reduced density of dopamine reuptake sites in
SAD patients was demonstrated (Tiihonen et al. 1997). An
IBZM-SPECT study found a lower D2-binding capacity in
SAD patients (Schneier et al. 2000).
In an open-label treatment trial (Kelsey et al. 2000) with
nefazodone correlates of social anxiety under stimulation
before treatment were obvious in the cortex bilaterally, the
medial temporal lobe, caudate nucleus, frontal lobe, and in
the lateral orbitofrontal cortex. Medial frontal lobe CBF
correlated with experienced anxiety to a high degree. After
treatment, CBF alterations with phobic stimulation still
could be seen in the right medial orbitofrontal cortex and
in the anterior cingulum. After successful treatment with
citalopram or a neurokinin-1 antagonist a reduced response
of the rhinal cortex, amygdala and the hippocampal area
during a public speaking task was detected in patients with
social phobia (Furmark et al. 2005). Another interesting
study by the same authors (Furmark et al. 2004) showed
that carriers of one or two copies of the short allele of the
serotonin transporter gene had, besides elevated levels of
trait- and state anxiety, a higher exitability of the right
amygdala to anxiety provocation compared to carriers of
two long allele copies.
Social anxiety disorder: concluding remarks
Following a neuroanatomical model by (Li et al. 2001)i t
has been proposed, that in SAD there was a dysfunction of
a cortico-striato-thalamic network. This could partially
stated by Sareen et al. (2007) showing a striatal dysfunction
associated with generalized social phobia. According to Li,
the parietal cortex plays an important role in the evaluation
of body position and the ‘‘social space’’. Via connections
between thalamus and basal ganglia there is an increased
transmission to the frontal cortex. A more negative eval-
uation of social situations would result and consequently
their avoidance. (Veit et al. 2002) presume a hyperactive
frontolimbic system that tends to misinterpret potentially
anxiety-inducing cues. Amir et al. (2005) stressed the
importance of the ACC in SAD in processing negative
emotional information. However, compared to patients
with posttraumatic stress disorder (PTSD), according to the
meta-analysis of Etkin and Wager (2007), SAD patients did
not show alterations of the ACC, although amygdala and
insula activity was higher than in healthy controls.
Social anxiety disorder seems to be characterized by
a hyperreactive (right) prefrontal cortex in combination
with a striatal dysfunction and increased hippocampus and
amygdalae activity with a lateralization to the left. Insula
activity goes in line with somatic anxiety, whereas the
ACC is important in anticipation of adverse stimuli.
Serotonergic drugs were consistently able to diminish these
phenomena according to clinical improvement.
Speciﬁc phobia
Speciﬁc phobia is a disorder characterized by an intense
and exaggerated fear of speciﬁc and isolated situations and
objects. Animal phobias are the most frequent subtype
(spiders, snakes, mice). Extreme anxiety symptoms might
emerged in the presence of the feared object, even thinking
about it may cause symptoms. Places where a confrontation
is expected are usually avoided. This may lead to restric-
tions in daily life, when e.g. a bedroom cannot be used or
the basement or the attic is avoided.
Straube et al. (2006a) found increased activation of the
left (but not right) amygdala, left insula, left anterior cin-
gulate, and left dorsomedial prefrontal cortex in fMRI
scans in phobics exposed to aversive (spider) versus neutral
(mushroom) images. In patients this phobic amygdala
activation appears to be stronger and shorter than in non-
phobics (Larson et al. 2006).
A greater response to fearful versus neutral faces of the
right insular cortex compared to controls was described by
(Wright et al. 2003). Amygdala hyperresponsivity was
not observed. Straube et al. 2004a, b showed that phobia
related words elicited activation in prefrontal cortex,
insula, and posterior cingulate cortex.
In patients with speciﬁc phobias, SPECT could discover
reduced tracer uptake in posterior brain regions under
710 K. Engel et al.
123phobic stimulation (O’Carroll et al. 1993). In spider phobia
Schienle et al. (2005) measured greater activation of the
visual association cortex, amygdalae, right dorsolateral
prefrontal cortex and right hippocampus. The supplemen-
tary motor area was activated, too.
Using [
15O]-PET in this patient group, a signiﬁcant
activation under phobic stimulation was measured in the
amygdalae and thalamus (Wik et al. 1997). In a population
of anxiety disorder patients of which only a part suffered
from speciﬁc phobias PET could detect regional CBF dif-
ferences with activation in the right frontal cortex, the right
postero-medial orbitofrontal cortex, in both insulae and
bilaterally in the nucleus lenticularis, and in the brainstem
(Rauch et al. 1995). PET-stimulation with spiders versus
butterﬂies in speciﬁc phobia revealed signal enhancement
in the left fusiform gyrus and right parahippocampal gyrus.
Habituation was seen in the anterior medial temporal lobe
bilaterally. State anxiety correlated with left amygdala
bilaterally, perirhinal cortex, right fusiform gyrus, and
PAG, whereas phobic fear correlated with right hippo-
campal activity (Veltman et al. 2004).
In an article on pathologic emotions (Reiman 1997),
associated brain regions to distinct functions on the base of
PET-studies. According to this theory, the anterior tem-
poral lobe is responsible for evaluation processes that
attach exteroceptive sensoric information to an emotional
component. The anterior insular areas combine potentially
fearful cognitive and sensory information to negative
emotion. Cingulum, vermis cerebelli, and midbrain regions
become activated in both, normal and pathologic anxiety.
The orbitofrontal cortex, the anterior insulae and the
anterior cingulate appear to be of particular relevance, as
they are possibly dysfunctional in all phobic disorders
(Malizia et al. 1997). Treatment studies (Straube et al.
2006b), however, showed that in fMRI speciﬁc phobics had
a reduction of previously hyperactivity of the insula
and ACC after successful cognitive behavioural therapy.
Goosens et al. (2007a) could demonstrate a reduction of
elevated baseline amygdala activation after 2 weeks of
exposure treatment to the feared stimuli and also a signif-
icant decline in the ACC and insular cortex. In a visual
stimulation study, using fMRI, besides amygdala and pul-
vinar nucleus of the hypothalamus activation increase,
ACC and left insula were stimulated more intensively
in patients compared to controls (Goosens et al. 2007b).
Schienle et al. (2007) reported decreased activation of the
medial orbitofrontal cortex in a pre-treatment exposure that
increased over the therapeutic process compared to a
waiting list group, a ﬁnding also reported by Hermann et al.
(2007) in patients exposed to phobia-relevant pictures
compared to controls. Amygdala and insula activity was
reduced with an experienced reduction of somatic anxiety
over the course of cognitive behavioural treatment
(Schienle et al. 2007). A greater activity of these two
structures linked to negative emotional responses was also
reported by the meta-analysis by Etkin and Wager (2007).
The bed nucleus of the stria terminalis as well as insula,
ACC and thalamus had a higher BOLD response in
anticipation of phobic versus neutral images in phobics
compared to controls. ACC and anterior prefrontal cortex
activity correlated with subjective anxiety in the patient
group (Straube et al. 2007).
Results from speciﬁc phobia investigations underpin the
theory of a hyperreactive amygdala more lateralized to the
left hemisphere (although no differential investigations on
conscious and unconscious perception of stimuli exist)
diminishing with successful treatment. Anticipation of
phobic stimulation activates the ACC and the insular cortex
which may characterize state anxiety or the expectancy of
adverse extero- and enteroception. Effects are decreasing
with syndrome improvement. The medial prefrontal cortex
appears to be hypoactive, although this has not been
demonstrated consistently.
Discussion
A multitude of research has been targeting on possible
brain regions involved in the origin of anxiety. Numerous
studies suggest that the amygdala is critical for the acqui-
sition and expression of fear. Conditioned fear in animals
has been considered as a good model for human anxiety
disorders, but animal models of anxiety have obvious
limitations. Conditioned fear in animals can be directed to
a speciﬁc stressor and is easily extinguished. Furthermore,
animals have a limited or lacking ability to develop the
capacity to worry excessively about the future. They do not
completely parallel the complex cognitive processes that
occur in anxious or even anxiety disorder ridden humans.
It can be assumed that human anxiety disorders are
caused to a certain extent by differential activity in certain
prefrontal cortex areas, the brain region that most separates
us from animals. The human prefrontal cortex has not only
been shown to be more developed than that of other
mammals, but it also has unique morphology and gene
expression. Neuroimaging studies consistently show
abnormalities in the prefrontal cortex in anxiety disorder
individuals. Thus, (Berkowitz et al. 2007) suggest that the
very same cortical complexity that allows us to produce
society and culture is also the origin of anxiety disorders.
Interestingly, preclinical and to a growing extent clinical
studies have shown that the prefrontal cortex inhibits the
amygdalae (the central nuclei). With the current knowledge
we have, it can be assumed that the amygdalae are acutely
activated when the individual is confronted to novel or
generally fearful stimuli. Learned experience that a stressor
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paying attention to, is characterized by distinct regional
prefrontal activation. This emotional processing can
decrease amygdalae activation or, when a solution is
lacking, leads to continuous limbic activation which is
lateralizing the more to the non-dominant side the worse
the stressor is perceived.
However, there appears to be a distinction between two
classes of anxiety disorders. Those disorders involving
intense fear and panic (panic disorder and speciﬁc phobias)
seem to be characterized by a hypoactivity of distinct
prefrontal cortex areas, thus desinhibiting the amygdalae.
Disorders which involve worry and rumination such as
generalized anxiety disorder or cognitions of negative
consequences of social behaviour (SAD), on the other
hand, seem to be characterized by a hyperactivity of the
prefrontal cortex.
Studies of prefrontal cortical function in psychiatric ill-
ness should be a fruitful method for identifying effective
treatment approaches. With improvements of methods a
more sophisticated evaluation of different executive func-
tions of the prefrontal cortex—and a differentiation
of orbitofrontal, medial frontal including cingulate cortex,
and dorsolateral prefrontal cortex functions will become
increasingly inevitable—a more reliable picture of the
neurocircuitry of anxiety disorders might emerge. In future
investigations lateralization phenomena will have to be
taken in account as important neurobiological features of
anxiety disorders as shifts of activation to the non-dominant
hemisphere with growing threat are commonly observed.
While previously mainly limbic structures were focus-
sed on in anxiety, besides the prefrontal areas, distinct
areas concerned with the perception of bodily states cannot
be neglected. The insular cortices seem to be deﬁnitely
involved in anxiety disorders contributing initiating and
maintaining inputs modulating prefrontal and limbic
structures in a way Damasio has described by the somatic
marker hypothesis (Damasio 1996).
Neuroimaging studies on the effect of psychotherapy in
patients suffering from diverse forms of psychopathology
indicate that the mental functions and processes involved in
diverse forms of psychotherapy exert a signiﬁcant inﬂuence
on brain activity (Beauregard 2007).
Beliefs and expectations can markedly modulate activity
in brain regions involved in perception, movement, pain,
and diverse aspects of emotion processing. Taken together,
the ﬁndings of neuroimaging studies strongly support the
view that the subjective nature and the intentional content
of anxiety-related processes (e.g., thoughts, feelings,
beliefs, volition) deﬁnitely modulates anxiety-network
functioning and plasticity.
Despite an overlap of certain phenomena that cannot be
ignored (unspeciﬁc alterations), anxiety in healthy subjects
does not equal anxiety in anxiety disorders and the different
disorders display distinct phenomena (besides expectable
unspeciﬁc ones) characterizing their particular psycho-
pathologic characteristics. Several controlled studies have
pointed out that healthy subjects showed activation of brain
region such as anxiety patients. However, phenomena are
usually signiﬁcantly more pronounced in patient groups.
Thus, anxiety syndromes involving a sensitized evalua-
tion of environmental aspects, cognitive dysfunction (such
as worries), spontaneous or situational panic detached from
higher (prefrontal) cortical control instances, motivational
aspects of avoidance combined with perception and
appraisal of enteroceptive phenomena of discomfort create
demarcable categories of disorders which become increas-
ingly investigable with neuroimaging techniques.
Future perspectives concerning neuroimaging in anxiety
disorders could become a useful tool in the control of
treatment effects, for the staging of disorder severity and
possibly for the identiﬁcation of variables that predispose
individuals to an expectable success or failure of a speciﬁc
therapeutic approach. Neuroimaging techniques could
support the diagnostic process of anxiety disorders and
support the inevitable rationale of implying biological
variables in the classiﬁcation of anxiety disorders, char-
acterizing speciﬁc endophenotypes.
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